Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristine Broglio

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
p53 expression as a prognostic marker in inflammatory breast cancerAna M Gonzalez-Angulo, Nour Sneige, Aman U Buzdar, et al.
Cancer|December 7, 2006
Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapyChafika Mazouni, Angeline Hall, Kristine Broglio, et al.
The Breast Journal|November 7, 2007
Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breastFlavia Morales-Vásquez, Ana Maria Gonzalez-Angulo, Kristine Broglio, et al.
Breast Cancer Research and Treatment|July 30, 2008
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrowAnthony Lucci, Savitri Krishnamurthy, Balraj Singh, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Building a predictive breast cancer risk modelConstance M Johnson, Joe Ensor, Kristine Broglio, et al.
The Breast Journal|July 15, 2010
Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved OutcomeShaheenah Dawood, Yun Gong, Kristine Broglio, et al.
Contemporary Clinical Trials|June 23, 2020
A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatmentCharles R Conway, Bryan Olin, Scott T Aaronson, et al.
Journal of Studies on Alcohol|November 13, 2004
Alcohol-related advice for Veterans Affairs primary care patients: Who gets it? Who gives it?Marcia L Burman, Daniel Kivlahan, Mara Buchbinder, et al.
Cancer|July 29, 2006
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approachMassimo Cristofanilli, Savitri Krishnamurthy, Laura Guerra, et al.
Cancer|July 25, 2007
Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experienceShaheenah Dawood, Ana M Gonzalez-Angulo, Florentia Peintinger, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
p53 expression as a prognostic marker in inflammatory breast cancerAna M Gonzalez-Angulo, Nour Sneige, Aman U Buzdar, et al.
Cancer|December 7, 2006
Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapyChafika Mazouni, Angeline Hall, Kristine Broglio, et al.
The Breast Journal|November 7, 2007
Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breastFlavia Morales-Vásquez, Ana Maria Gonzalez-Angulo, Kristine Broglio, et al.
Breast Cancer Research and Treatment|July 30, 2008
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrowAnthony Lucci, Savitri Krishnamurthy, Balraj Singh, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Building a predictive breast cancer risk modelConstance M Johnson, Joe Ensor, Kristine Broglio, et al.
The Breast Journal|July 15, 2010
Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved OutcomeShaheenah Dawood, Yun Gong, Kristine Broglio, et al.
Contemporary Clinical Trials|June 23, 2020
A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatmentCharles R Conway, Bryan Olin, Scott T Aaronson, et al.
Journal of Studies on Alcohol|November 13, 2004
Alcohol-related advice for Veterans Affairs primary care patients: Who gets it? Who gives it?Marcia L Burman, Daniel Kivlahan, Mara Buchbinder, et al.
Cancer|July 29, 2006
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approachMassimo Cristofanilli, Savitri Krishnamurthy, Laura Guerra, et al.
Cancer|July 25, 2007
Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experienceShaheenah Dawood, Ana M Gonzalez-Angulo, Florentia Peintinger, et al.
Pageof 10